NewsBenzinga레플리뮨 그룹, 절제 불가능한 진행성 피부 흑색종 치료제 ‘투드리케브’ 미국 상업적 출시 발표 레플리뮨 그룹, 절제 불가능한 진행성 피부 흑색종 치료제 ‘투드리케브’ 미국 상업적 출시 발표 Benzinga 2026.10.01 20:02 (GMT+0) Open on Benzinga Other news Vylor Added to the S&P 500; Twilio Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Nike Stock Sinks to Lowest Level Since 2013 after Q1 Earnings Brady Corporation Announces Sale Of Its Securimed SAS Business For ~$59M Here’s How Much You Would Have Made Owning Aramark Stock In The Last 5 Years Nike Executive On China Says We Expect Our Digital Cleanup To Take Multiple Seasons Nike Executive Says We Will Deliberately Reduce Volume & Frequency Of Specific Jordan Retro Launches
Vylor Added to the S&P 500; Twilio Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
